Correlation Between Spyre Therapeutics and Manaris Corp
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Manaris Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Manaris Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Manaris Corp, you can compare the effects of market volatilities on Spyre Therapeutics and Manaris Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Manaris Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Manaris Corp.
Diversification Opportunities for Spyre Therapeutics and Manaris Corp
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spyre and Manaris is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Manaris Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Manaris Corp and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Manaris Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Manaris Corp has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Manaris Corp go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Manaris Corp
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 2.89 times less return on investment than Manaris Corp. But when comparing it to its historical volatility, Spyre Therapeutics is 2.87 times less risky than Manaris Corp. It trades about 0.04 of its potential returns per unit of risk. Manaris Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 0.01 in Manaris Corp on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Manaris Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Spyre Therapeutics vs. Manaris Corp
Performance |
| Timeline |
| Spyre Therapeutics |
| Manaris Corp |
Spyre Therapeutics and Manaris Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Manaris Corp
The main advantage of trading using opposite Spyre Therapeutics and Manaris Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Manaris Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manaris Corp will offset losses from the drop in Manaris Corp's long position.| Spyre Therapeutics vs. Cirmaker Technology | Spyre Therapeutics vs. EMCORE | Spyre Therapeutics vs. BE Semiconductor Industries | Spyre Therapeutics vs. Asure Software |
| Manaris Corp vs. Cheche Group Class | Manaris Corp vs. Senmiao Technology | Manaris Corp vs. Allient | Manaris Corp vs. Radcom |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |